Ensign Peak Advisors
MRK icon

Ensign Peak Advisors’s Merck MRK Stock Holding History

Ensign Peak Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314M Buy
2,613,009
+774,766
+42% +$89.4M 0.59% 27
2025
Q4 		$193M Sell
1,838,243
-933,782
-34% -$87.7M 0.34% 55
2025
Q3 		$233M Sell
2,772,025
-379,724
-12% -$31.3M 0.38% 48
2025
Q2 		$249M Buy
3,151,749
+536,384
+21% +$42.6M 0.43% 48
2025
Q1 		$235M Sell
2,615,365
-56,207
-2% -$5.25M 0.45% 46
2024
Q4 		$266M Sell
2,671,572
-1,035,243
-28% -$107M 0.47% 44
2024
Q3 		$421M Sell
3,706,815
-392,028
-10% -$46.6M 0.74% 21
2024
Q2 		$507M Sell
4,098,843
-832,195
-17% -$107M 0.93% 15
2024
Q1 		$651M Sell
4,931,038
-164,159
-3% -$20.2M 1.19% 12
2023
Q4 		$555M Sell
5,095,197
-303,289
-6% -$31.5M 1.1% 12
2023
Q3 		$556M Buy
5,398,486
+122,990
+2% +$13.3M 1.19% 13
2023
Q2 		$609M Sell
5,275,496
-119,276
-2% -$13.5M 1.23% 14
2023
Q1 		$574M Buy
5,394,772
+532,288
+11% +$57.5M 1.24% 13
2022
Q4 		$539M Buy
4,862,484
+71,207
+1% +$7.28M 1.22% 11
2022
Q3 		$413M Buy
4,791,277
+469,758
+11% +$41.9M 1.03% 14
2022
Q2 		$394M Buy
4,321,519
+2,362,744
+121% +$209M 0.94% 17
2022
Q1 		$161M Buy
1,958,775
+532,676
+37% +$42M 0.33% 69
2021
Q4 		$109M Sell
1,426,099
-1,315,527
-48% -$105M 0.21% 106
2021
Q3 		$206M Sell
2,741,626
-208,676
-7% -$15.9M 0.43% 56
2021
Q2 		$229M Sell
2,950,302
-697,244
-19% -$51.9M 0.46% 55
2021
Q1 		$268M Sell
3,647,546
-452,455
-11% -$33.4M 0.58% 34
2020
Q4 		$320M Sell
4,100,001
-237,474
-5% -$18.2M 0.73% 26
2020
Q3 		$343M Sell
4,337,475
-575,311
-12% -$45.1M 0.87% 18
2020
Q2 		$363M Sell
4,912,786
-521,551
-10% -$39.3M 0.99% 14
2020
Q1 		$399M Buy
5,434,337
+606,712
+13% +$47.7M 1.34% 10
2019
Q4 		$419M Buy
+4,827,625
New +$397M 1.11% 11

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ensign Peak Advisors's MRK Position: Q1 2026 in Review

Ensign Peak Advisors increased its Merck (MRK) stake by 42% in Q1 2026, buying an estimated $89.4M and bringing the position to 2,613,009 shares worth $314M. The position accounts for 0.59% of the portfolio, ranked #27.

Ensign Peak Advisors first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. The position peaked at $651M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ensign Peak Advisors held 2,613,009 shares of Merck worth $314M as of Q1 2026.
  • Ensign Peak Advisors bought 774,766 Merck shares in Q1 2026, an estimated $89.4M.
  • Merck made up 0.59% of Ensign Peak Advisors's portfolio in Q1 2026, its #27 holding.
  • Ensign Peak Advisors first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • Ensign Peak Advisors's Merck position peaked at $651M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.